ImmunityBio, Inc. Annual Operating Margin in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
ImmunityBio, Inc. quarterly/annual Operating Margin history and growth rate from 2014 to 2023.
  • ImmunityBio, Inc. Operating Margin for the quarter ending March 31, 2024 was -115K %, a 82.9% decline year-over-year.
  • ImmunityBio, Inc. annual Operating Margin for 2023 was -58.2K %, a 60.2% increase from 2022.
  • ImmunityBio, Inc. annual Operating Margin for 2022 was -146K %, a 314% decline from 2021.
  • ImmunityBio, Inc. annual Operating Margin for 2021 was -35.4K %, a 3.14% increase from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -58.2K +88.1K +60.2% Jan 1, 2023 Dec 31, 2023
2022 -146K -111K -314% Jan 1, 2022 Dec 31, 2022
2021 -35.4K +1.15K +3.14% Jan 1, 2021 Dec 31, 2021
2020 -36.5K -29.4K -415% Jan 1, 2020 Dec 31, 2020
2019 -7.1K +202K +96.6% Jan 1, 2019 Dec 31, 2019
2018 -209K +10.9K +4.96% Jan 1, 2018 Dec 31, 2018
2017 -220K +62.7K +22.2% Jan 1, 2017 Dec 31, 2017
2016 -283K -182K -180% Jan 1, 2016 Dec 31, 2016
2015 -101K -100K -11538% Jan 1, 2015 Dec 31, 2015
2014 -870 Jan 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.